Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

IM Cannabis Corp. (IMCC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.7290+0.0090 (+1.25%)
At close: 03:59PM EDT
0.7550 +0.03 (+3.57%)
After hours: 07:50PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close0.7200
Open0.7340
Bid0.6939 x 800
Ask0.7550 x 1800
Day's Range0.6901 - 0.7599
52 Week Range0.6500 - 5.4800
Volume80,332
Avg. Volume196,022
Market Cap53.248M
Beta (5Y Monthly)2.17
PE Ratio (TTM)N/A
EPS (TTM)-0.5840
Earnings DateMay 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.47
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for IMCC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IM Cannabis Corp.
    Analyst Report: Becton, Dickinson And Co.Headquartered in Franklin Lakes, New Jersey, BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry, and the general public. Its operations consist of three worldwide business segments: BD Medical, BD Life Sciences, and BD Interventional.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • GlobeNewswire

    The Flowr Corporation Announces Fourth Quarter and Full Year 2021 Results

    Highlights: In 2021, the Company generated gross revenue of approximately $14.9 million and generated gross revenue of $4.3 million during the fourth quarter.During the year, the Company sold 6,627,052 grams of dried cannabis flower, an increase of 372% as compared to the prior year.The Company has expanded in format sizes beyond is signature 3.5 gram jars to include 7 gram and 14 gram bags. Flowr launched BC Dog Walkers in Ontario, British Columbia, and Alberta. The BC Dog Walkers highlight the

  • PR Newswire

    IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million

    IM Cannabis Corp. (the "Company", "IM Cannabis", or "IMC") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, provided financial results for the three months ended March 31, 2022. All amounts are reported in Canadian dollars unless otherwise stated.

  • PR Newswire

    IM Cannabis to Report First Quarter 2022 Financial Results on Thursday, May 12 at 5:00 p.m. ET

    IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, will report operational and financial results for the first quarter ended March 31, 2022 after market close on Thursday, May 12, 2022.

Advertisement
Advertisement